| Members |
targetComponentId |
| [X]Other bacterial diseases |
Bacterial infectious disease |
| [X]Other diseases of the respiratory system |
Disorder of respiratory system (disorder) |
| [X]Other disorders of skin and subcutaneous tissue in diseases classified elsewhere |
Disorder of skin and/or subcutaneous tissue (disorder) |
| [X]Other disorders of the skin and subcutaneous tissue |
Disorder of skin and/or subcutaneous tissue (disorder) |
| [X]Other leukemia of unspecified cell type |
Leukaemia |
| [X]Other retinal disorders in diseases classified elsewhere |
Retinal disorder |
| [X]Other specified bacterial diseases |
Bacterial infectious disease |
| [X]Other specified cerebrovascular diseases |
Cerebrovascular disease |
| [X]Other specified diseases of pericardium |
Disorder of pericardium |
| [X]Other specified diseases of spinal cord |
Spinal cord disorder (disorder) |
| [X]Other specified disorders of the central nervous system |
Disorder of the central nervous system (disorder) |
| [X]Other specified disorders of the skin and subcutaneous tissue |
Disorder of skin and/or subcutaneous tissue (disorder) |
| [X]Other specified endocrine disorders |
Disorder of endocrine system |
| [X]Other specified retinal disorders |
Retinal disorder |
| alpha-Aminoacylpeptide hydrolase |
Alpha-aminoacylpeptide hydrolase (substance) |
| beta Carotene |
Betacarotene |
| cDE genotype |
cDE haplotype (finding) |
| cDe genotype |
cDe haplotype (finding) |
| cdE genotype |
cdE haplotype (finding) |
| cde genotype |
cde haplotype (finding) |
| de Quervain's disease |
Radial styloid tenosynovitis |
| kV |
kilovolt |
| lotrozole |
Product containing letrozole (medicinal product) |
| mA |
mA - milliampere |
| mV |
millivolt (qualifier value) |
| n-1-Naphthyl sodium salt |
Herbicide |
| p-Amino diphenylamine |
4-aminobiphenyl (substance) |
| pM category finding |
American Joint Committee on Cancer pathological M category allowable value (qualifier value) |
| pM0 category |
American Joint Committee on Cancer cM0 (qualifier value) |
| pM0: No distant metastasis (breast) |
American Joint Committee on Cancer cM0 (qualifier value) |
| pM1 (IV): Distant metastasis (TNM category and FIGO stage) (fallopian tube) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IV): Distant metastasis (TNM category and FIGO stage) (ovary) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (corpus uteri) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (uterine cervix) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Distant metastasis (TNM category and FIGO stage) (vagina) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 (IVB): Distant metastasis (including pelvic lymph node metastasis) (TNM category and FIGO stage) (vulva) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1 category |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1: Distant metastasis (breast) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1: Distant metastasis, includes separate tumor nodule(s) in a different lobe (ipsilateral or contralateral) (lung) |
American Joint Committee on Cancer pM1 (qualifier value) |
| pM1a (III): Tumor extends to the lungs with or without genital tract involvement (TNM category and FIGO stage) (gestational trophoblast) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a category |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis (esophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis not applicable (midthoracic esophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis to bone marrow (retinoblastoma) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis to lung (bone) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis to lung (primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Distant metastasis to non-regional lymph node(s) (prostate) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Metastasis in celiac lymph nodes (lower thoracic esophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Metastasis in cervical nodes (upper thoracic esophagus) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Metastasis to skin, subcutaneous tissues, or distant lymph nodes (melanoma of the skin) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1a: Non-regional nodal or pulmonary metastasis (testis) |
American Joint Committee on Cancer pM1a (qualifier value) |
| pM1b (IV): Distant metastasis other than lung (TNM category and FIGO stage) (gestational trophoblast) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b category |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis (esophagus) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis other than to non-regional lymph nodes and lungs (testis) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to bone(s) (prostate) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to site other than celiac lymph nodes (lower thoracic esophagus) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to site other than cervical nodes (upper thoracic esophagus) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to site other than lung (bone) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to site other than lung (primitive neuroectodermal tumor/Ewing's sarcoma) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Distant metastasis to sites other than bone marrow (retinoblastoma) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Metastasis to lung (melanoma of the skin) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1b: Nonregional lymph nodes and/or other distant metastasis (midthoracic esophagus) |
American Joint Committee on Cancer pM1b (qualifier value) |
| pM1c category |
pM1c |
| pM1c: Distant metastasis site other than bone or non-regional lymph node(s) (prostate) |
pM1c |
| pM1c: Metastasis to visceral site other than lung or distant metastasis at any site associated with an elevated serum lactic dehydrogenase (melanoma of the skin) |
pM1c |
| pMX category |
American Joint Committee on Cancer cM0 (qualifier value) |
| pMX: Distant metastasis cannot be assessed (breast) |
American Joint Committee on Cancer cM0 (qualifier value) |
| pN category finding |
American Joint Committee on Cancer pathological N category allowable value (qualifier value) |
| pN0 category |
pN0 |
| pN0(i+) category |
pN0(i+) |
| pN0(i+): No regional lymph node metastasis histologically, positive IHC, no IHC cluster greater than 0.2 mm (breast) |
pN0(i+) |
| pN0(i+): No regional lymph node metastasis histologically, positive morphologic findings for isolated tumor cells, no cluster greater than 0.2 mm (breast) |
pN0(i+) |
| pN0(i-) category |
pN0 |
| pN0(i-): No regional lymph node metastasis histologically, negative IHC (breast) |
pN0 |
| pN0(i-): No regional lymph node metastasis histologically, negative morphologic findings for isolated tumor cells (breast) |
pN0 |
| pN0(mol+) category |
American Joint Committee on Cancer pN0(mol+) (qualifier value) |
| pN0(mol+): No regional lymph node metastasis histologically, positive molecular findings (breast) |
American Joint Committee on Cancer pN0(mol+) (qualifier value) |
| pN0(mol+): No regional lymph node metastasis histologically, positive nonmorphologic (molecular) findings for isolated tumor cells (breast) |
American Joint Committee on Cancer pN0(mol+) (qualifier value) |
| pN0(mol-) category |
pN0 |
| pN0(mol-): No regional lymph node metastasis histologically, negative molecular findings (breast) |
pN0 |
| pN0(mol-): No regional lymph node metastasis histologically, negative nonmorphologic (molecular) findings for isolated tumor cells (breast) |
pN0 |
| pN0: No regional lymph node metastasis histologically (i.e., none greater than 0.2 mm), no additional examination for isolated tumor cells (breast) |
pN0 |
| pN1 (III): Pelvic or inguinal lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vagina) |
pN1 |
| pN1 (III): Unilateral regional lymph node metastasis (pT1-pT3) (TNM category and FIGO stage) (vulva) |
pN1 |
| pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (corpus uteri) |
pN1 |
| pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) |
pN1 |
| pN1 (IIIC): Regional lymph node metastasis (TNM category and FIGO stage) (ovary) |
pN1 |
| pN1 (IVA): Pelvic or inguinal lymph node metastasis (pT4) (TNM category and FIGO stage) (vagina) |
pN1 |
| pN1 (IVA): Unilateral regional lymph node metastasis (pT4) (TNM category and FIGO stage) (vulva) |
pN1 |
| pN1 (IVB): Pelvic or inguinal lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vagina) |
pN1 |
| pN1 (IVB): Unilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva) |
pN1 |
| pN1 category |
pN1 |
| pN1: Metastasis in 1 to 3 axillary lymph nodes, and/or in internal mammary nodes with microscopic disease detected by sentinel lymph node dissection but not clinically apparent (breast) |
pN1 |
| pN1: Metastasis in 1 to 3 regional lymph nodes (colon/rectum) |
pN1 |
| pN1: Metastasis in 1 to 6 regional (perigastric) lymph nodes (stomach) |
pN1 |
| pN1: Metastasis in a single ipsilateral lymph node, 3 cm or less in greatest dimension (upper aerodigestive tract) |
pN1 |
| pN1: Metastasis in a single lymph node, 2 cm or less in greatest dimension (urinary bladder, ureter, renal pelvis) |
pN1 |
| pN1: Metastasis in a single regional lymph node (kidney) |
pN1 |
| pN1: Metastasis in ipsilateral peribronchial and/or ipsilateral hilar lymph nodes, including intrapulmonary nodes involved by direct extension of the primary tumor (lung) |
pN1 |
| pN1: Metastasis in one regional lymph node (melanoma of the skin) |
pN1 |
FHIR